Logos Global Management LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-10-22 12:27 pm Purchase | 2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX | Logos Global Management LP | 1,700,000 4.300% | 1,700,000 (New Position) | Filing |